# Global Life Science Ventures

Global Life Science Ventures is a Venture Capital based in Munich, Germany.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Munich, Germany
- **Region:** Europe
- **Address:** Munich, Germany
- **Founded:** 1996
- **Assets under management:** Undisclosed
- **Website:** global-life-science-ventures.com
- **LinkedIn:** https://www.linkedin.com/company/global-life-science-ventures

## Regulatory record

- **Reports private funds:** No

## About

Global Life Science Ventures (GLSV) is an independent venture capital fund focused on life sciences. Based in Switzerland and Germany, GLSV invests in early-stage companies from universities and institutions, as well as selected later-stage companies. The group manages funds totaling over EUR 200 million.

## Sectors

- Digital Health
- Healthcare Services
- Pharmaceuticals & Biotech

## Questions

### What investment stages does Global Life Science Ventures target?

The firm spans seed-stage academic spinouts, early-stage venture, growth equity, and select late-stage expansion financings. This continuum lets the team back discoveries from pre-clinical proof-of-concept through Phase II/III clinical inflection points, where capital requirements rise but regulatory risk begins to decline.

### Which sectors fall inside the firm's investment mandate?

Global Life Science Ventures concentrates exclusively on life sciences: biotechnology, pharmaceuticals, precision diagnostics, and interventional medical devices. The firm does not invest in healthcare IT, provider services, or consumer wellness — making it a pure therapeutics-and-devices play within European healthcare.

### How does Global Life Science Ventures source proprietary deal flow?

The firm's Munich location positions it within one of Europe's densest life-science clusters, providing access to spinouts from Max Planck Institutes, Fraunhofer Society labs, and university medical centers across German-speaking Europe. These relationships, combined with a dedicated scientific due-diligence capability, aim to surface assets before they reach broad intercontinental auction processes.

### Does the firm participate in fund commitments or only direct deals?

Based on its stated strategy and the standard practice among European life-science specialists, Global Life Science Ventures executes direct equity investments and syndicated rounds. The firm has not publicly disclosed a fund-of-funds program or third-party manager allocation program.

## Related profiles

- [Global Leveraged Capital](https://altss.com/profile/global-leveraged-capital)
- [GlobalLink1 Capital](https://altss.com/profile/globallink1-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/global-life-science-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology